ASC-话题@MedSci

#ASC#

1352篇内容 | 3100人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1939361, encodeId=55191939361bc, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=Cardiovasc Diabetol：不同他汀类药物对新发糖尿病风险的影响, objectType=article, longId=727775, objectId=9479e277750a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9479e277750a, replyNumber=0, likeNumber=32, createdTime=2022-12-26, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9479e277750a, moduleTitle=Cardiovasc Diabetol：不同他汀类药物对新发糖尿病风险的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9479e277750a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939375, encodeId=458719393e54d, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=ASCO 2022 | 心脏代谢和腹部脂肪对女性乳腺癌患者身体功能的影响, objectType=article, longId=728356, objectId=f01ee283560f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f01ee283560f, replyNumber=0, likeNumber=28, createdTime=2022-10-03, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f01ee283560f, moduleTitle=ASCO 2022 | 心脏代谢和腹部脂肪对女性乳腺癌患者身体功能的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f01ee283560f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939441, encodeId=48561939441db, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=Cardiovasc Diabetol：甘油三酯血糖指数检测冠心病患者不同糖代谢状态下冠状动脉病变的严重程度, objectType=article, longId=729716, objectId=2c6ee29716bc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2c6ee29716bc, replyNumber=0, likeNumber=31, createdTime=2023-04-15, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2c6ee29716bc, moduleTitle=Cardiovasc Diabetol：甘油三酯血糖指数检测冠心病患者不同糖代谢状态下冠状动脉病变的严重程度, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2c6ee29716bc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939442, encodeId=de00193944290, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=ASCO 2022：秦叔逵、李进教授发现尼妥珠单抗联合吉西他滨可提高胰腺癌患者疗效, objectType=article, longId=729412, objectId=4900e294125e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4900e294125e, replyNumber=0, likeNumber=43, createdTime=2023-02-08, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4900e294125e, moduleTitle=ASCO 2022：秦叔逵、李进教授发现尼妥珠单抗联合吉西他滨可提高胰腺癌患者疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4900e294125e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939422, encodeId=bb5119394221c, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=ASCO2022：机会之窗临床实验，胶质母细胞瘤的曙光, objectType=article, longId=728706, objectId=41d8e2870685, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=41d8e2870685, replyNumber=0, likeNumber=34, createdTime=2022-09-09, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=41d8e2870685, moduleTitle=ASCO2022：机会之窗临床实验，胶质母细胞瘤的曙光, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=41d8e2870685)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939468, encodeId=57c2193946861, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=Cardiovasc Diabetol ：循环代谢物和分子脂质种类与1型糖尿病未来心血管发病率和死亡率相关, objectType=article, longId=734138, objectId=c9d7e341381c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c9d7e341381c, replyNumber=0, likeNumber=42, createdTime=2023-01-04, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c9d7e341381c, moduleTitle=Cardiovasc Diabetol ：循环代谢物和分子脂质种类与1型糖尿病未来心血管发病率和死亡率相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c9d7e341381c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939409, encodeId=c829193940972, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=ASCO 2022 | 与酒精相关的癌症发病率不断上升，患上这种癌症的风险最高！, objectType=article, longId=728538, objectId=790ce2853873, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=790ce2853873, replyNumber=0, likeNumber=36, createdTime=2023-03-06, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=790ce2853873, moduleTitle=ASCO 2022 | 与酒精相关的癌症发病率不断上升，患上这种癌症的风险最高！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=790ce2853873)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939480, encodeId=e77719394809c, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=Cardiovasc Diabetol：SGLT2抑制剂在糖尿病合并心力衰竭患者中的当代应用情况, objectType=article, longId=736137, objectId=47e3e3613704, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=47e3e3613704, replyNumber=0, likeNumber=46, createdTime=2023-04-13, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=47e3e3613704, moduleTitle=Cardiovasc Diabetol：SGLT2抑制剂在糖尿病合并心力衰竭患者中的当代应用情况, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=47e3e3613704)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939430, encodeId=bfaf19394305f, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=Cardiovasc Diabetol：循环糖基化终产物及其受体水平可预测糖尿病患者的全因死亡和心血管事件风险, objectType=article, longId=728875, objectId=1e81e28875c4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1e81e28875c4, replyNumber=0, likeNumber=29, createdTime=2022-06-08, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1e81e28875c4, moduleTitle=Cardiovasc Diabetol：循环糖基化终产物及其受体水平可预测糖尿病患者的全因死亡和心血管事件风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1e81e28875c4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939347, encodeId=719c193934e67, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=Cardiovasc Diabetol：糖尿病肾病患者中SGLT2抑制剂与心血管、肾脏和安全性结局的关系, objectType=article, longId=725589, objectId=2d1de25589ae, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2d1de25589ae, replyNumber=0, likeNumber=35, createdTime=2022-11-24, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2d1de25589ae, moduleTitle=Cardiovasc Diabetol：糖尿病肾病患者中SGLT2抑制剂与心血管、肾脏和安全性结局的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2d1de25589ae)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939376, encodeId=5ac119393e647, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=2022 ASCO: 筛查、早期治疗和转移性治疗对降低乳腺癌死亡率的影响, objectType=article, longId=728365, objectId=6905e2836591, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6905e2836591, replyNumber=0, likeNumber=39, createdTime=2022-11-28, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6905e2836591, moduleTitle=2022 ASCO: 筛查、早期治疗和转移性治疗对降低乳腺癌死亡率的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6905e2836591)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939460, encodeId=caf319394608e, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=Cardiovasc Diabetol：急性心肌梗死后糖尿病患者和非糖尿病患者入院后高血糖的短期和长期预后, objectType=article, longId=733001, objectId=ee4ee3300185, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ee4ee3300185, replyNumber=0, likeNumber=38, createdTime=2023-06-27, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ee4ee3300185, moduleTitle=Cardiovasc Diabetol：急性心肌梗死后糖尿病患者和非糖尿病患者入院后高血糖的短期和长期预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ee4ee3300185)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939363, encodeId=9940193936397, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=Cardiovasc Diabetol：血浆动脉粥样硬化指数与心血管疾病风险的相关性, objectType=article, longId=728162, objectId=54eee2816228, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=54eee2816228, replyNumber=0, likeNumber=0, createdTime=2023-01-03, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=54eee2816228, moduleTitle=Cardiovasc Diabetol：血浆动脉粥样硬化指数与心血管疾病风险的相关性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=54eee2816228)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939380, encodeId=0f6919393803e, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=ASCO：Sintilimab联合CapeOx和贝伐单抗一线治疗RAS突变+转移性结直肠癌, objectType=article, longId=728247, objectId=5740e2824790, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5740e2824790, replyNumber=0, likeNumber=32, createdTime=2022-10-03, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5740e2824790, moduleTitle=ASCO：Sintilimab联合CapeOx和贝伐单抗一线治疗RAS突变+转移性结直肠癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5740e2824790)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939457, encodeId=8ea9193945e8e, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=周清教授 | 首个PD-1抑制剂头对头研究结果在2022 ASCO公布，中国创新药物彰显实力, objectType=article, longId=731997, objectId=1efbe3199786, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1efbe3199786, replyNumber=0, likeNumber=41, createdTime=2023-05-09, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1efbe3199786, moduleTitle=周清教授 | 首个PD-1抑制剂头对头研究结果在2022 ASCO公布，中国创新药物彰显实力, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1efbe3199786)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939370, encodeId=e39319393e065, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=2022 ASCO：YAP-1对ES-SCLC患者免疫治疗疗效的预测价值, objectType=article, longId=728254, objectId=ce42e2825488, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ce42e2825488, replyNumber=0, likeNumber=40, createdTime=2022-07-30, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ce42e2825488, moduleTitle=2022 ASCO：YAP-1对ES-SCLC患者免疫治疗疗效的预测价值, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ce42e2825488)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939402, encodeId=f0da1939402e6, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=ASCO2022：除癌症分级与分期外，这些因素也会影响上尿路上皮癌患者的预后, objectType=article, longId=728376, objectId=7668e283761c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7668e283761c, replyNumber=0, likeNumber=31, createdTime=2023-04-21, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7668e283761c, moduleTitle=ASCO2022：除癌症分级与分期外，这些因素也会影响上尿路上皮癌患者的预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7668e283761c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939451, encodeId=0beb1939451bc, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=Front Cardiovasc Med：L-精氨酸能改善高血压体弱老年人的认知障碍, objectType=article, longId=730962, objectId=d18de3096214, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d18de3096214, replyNumber=0, likeNumber=47, createdTime=2023-05-29, rootId=0, userName=医者仁心, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d18de3096214, moduleTitle=Front Cardiovasc Med：L-精氨酸能改善高血压体弱老年人的认知障碍, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d18de3096214)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939435, encodeId=75b619394352f, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=ASCO 2022 | NeoSTAR临床小试牛刀：戈沙妥珠单抗开辟早期TNBC「新地图」！, objectType=article, longId=728859, objectId=6913e288595a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6913e288595a, replyNumber=0, likeNumber=56, createdTime=2022-09-11, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6913e288595a, moduleTitle=ASCO 2022 | NeoSTAR临床小试牛刀：戈沙妥珠单抗开辟早期TNBC「新地图」！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6913e288595a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939407, encodeId=7aff193940e6b, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=2022 ASCO：通过个性化和肿瘤知情的ctDNA检测监测肝细胞癌患者肝脏移植后疾病复发的可行性, objectType=article, longId=728361, objectId=4a1be2836132, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4a1be2836132, replyNumber=0, likeNumber=42, createdTime=2022-07-13, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4a1be2836132, moduleTitle=2022 ASCO：通过个性化和肿瘤知情的ctDNA检测监测肝细胞癌患者肝脏移植后疾病复发的可行性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4a1be2836132)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

ASC

2020-05-29

quxin068 (审核中...)

前往app查看评论内容

#ASC#

Cardiovasc Diabetol：不同他汀类药物对新发糖尿病风险的影响

2022-12-26

quxin068 (审核中...)

前往app查看评论内容

#ASC#

ASCO 2022 | 心脏代谢和腹部脂肪对女性乳腺癌患者身体功能的影响

2022-10-03

quxin068 (审核中...)

前往app查看评论内容

#ASC#

Cardiovasc Diabetol：甘油三酯血糖指数检测冠心病患者不同糖代谢状态下冠状动脉病变的严重程度

2023-04-15

quxin068 (审核中...)

前往app查看评论内容

#ASC#

ASCO 2022：秦叔逵、李进教授发现尼妥珠单抗联合吉西他滨可提高胰腺癌患者疗效

2023-02-08

quxin068 (审核中...)

前往app查看评论内容

#ASC#

ASCO2022：机会之窗临床实验，胶质母细胞瘤的曙光

2022-09-09

quxin068 (审核中...)

前往app查看评论内容

#ASC#

Cardiovasc Diabetol ：循环代谢物和分子脂质种类与1型糖尿病未来心血管发病率和死亡率相关

2023-01-04

quxin068 (审核中...)

前往app查看评论内容

#ASC#

ASCO 2022 | 与酒精相关的癌症发病率不断上升，患上这种癌症的风险最高！

2023-03-06

quxin068 (审核中...)

前往app查看评论内容

#ASC#

Cardiovasc Diabetol：SGLT2抑制剂在糖尿病合并心力衰竭患者中的当代应用情况

2023-04-13

quxin068 (审核中...)

前往app查看评论内容

#ASC#

Cardiovasc Diabetol：循环糖基化终产物及其受体水平可预测糖尿病患者的全因死亡和心血管事件风险

2022-06-08

quxin068 (审核中...)

前往app查看评论内容

#ASC#

Cardiovasc Diabetol：糖尿病肾病患者中SGLT2抑制剂与心血管、肾脏和安全性结局的关系

2022-11-24

quxin068 (审核中...)

前往app查看评论内容

#ASC#

2022 ASCO: 筛查、早期治疗和转移性治疗对降低乳腺癌死亡率的影响

2022-11-28

quxin068 (审核中...)

前往app查看评论内容

#ASC#

Cardiovasc Diabetol：急性心肌梗死后糖尿病患者和非糖尿病患者入院后高血糖的短期和长期预后

2023-06-27

quxin068 (审核中...)

前往app查看评论内容

#ASC#

Cardiovasc Diabetol：血浆动脉粥样硬化指数与心血管疾病风险的相关性

2023-01-03

quxin068 (审核中...)

前往app查看评论内容

#ASC#

ASCO：Sintilimab联合CapeOx和贝伐单抗一线治疗RAS突变+转移性结直肠癌

2022-10-03

quxin068 (审核中...)

前往app查看评论内容

#ASC#

周清教授 | 首个PD-1抑制剂头对头研究结果在2022 ASCO公布，中国创新药物彰显实力

2023-05-09

quxin068 (审核中...)

前往app查看评论内容

#ASC#

2022 ASCO：YAP-1对ES-SCLC患者免疫治疗疗效的预测价值

2022-07-30

quxin068 (审核中...)

前往app查看评论内容

#ASC#

ASCO2022：除癌症分级与分期外，这些因素也会影响上尿路上皮癌患者的预后

2023-04-21

医者仁心 (审核中...)

前往app查看评论内容

#ASC#

Front Cardiovasc Med：L-精氨酸能改善高血压体弱老年人的认知障碍

2023-05-29

quxin068 (审核中...)

前往app查看评论内容

#ASC#

ASCO 2022 | NeoSTAR临床小试牛刀：戈沙妥珠单抗开辟早期TNBC「新地图」！

2022-09-11

quxin068 (审核中...)

前往app查看评论内容

#ASC#

2022 ASCO：通过个性化和肿瘤知情的ctDNA检测监测肝细胞癌患者肝脏移植后疾病复发的可行性

2022-07-13

科室
- - 订阅+
  - 更多科室
工具
服务